Sphera Funds Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Sphera Funds Management's GILD Position: Q1 2024 in Review
Sphera Funds Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 20,000 shares — an estimated $1.62M sold.
Sphera Funds Management first reported a position in GILD in Q4 2013 and held it in 22 quarters. The position peaked at $37.5M in Q2 2015. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.
- Sphera Funds Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
- Sphera Funds Management sold 20,000 Gilead Sciences shares in Q1 2024, an estimated $1.62M.
- Sphera Funds Management first reported a position in Gilead Sciences in Q4 2013 and held it in 22 quarters.
- Sphera Funds Management's Gilead Sciences position peaked at $37.5M in Q2 2015.
- 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.
Based on Sphera Funds Management's 13F filing for Q1 2024, filed 15 May 2024.